Recently, we reported that FT895, a specific HDAC11 inhibitor, could synergistically enhance the cytotoxicity of cordycepin in MPNST cells, especially in the less cordycepin-sensitive cell line, S462TY. Here, HDAC11 is linked to malignant peripheral nerve sheath tumor.